The World's First Biotechnology-driven "Blue Roses" -synonym for the impossible -

have been successfully developed

SUNTORY LIMITED (Head Office:Osaka City, Japan / President:Nobutada Saji), jointly

with Florigene Pty. Ltd. (Victoria, Australia / President:Toshihiko Ashikari - SUNTORY
holds 98.5% of Florigene's shares), has successfully developed the world's first
biotechnology-driven "blue rose".

Roses have been grown for a long time - 5,000 years or more. It is said that the varieties
developed to more than 25,000 species and a wide variety of colours exists including red, white, pink and yellow. For a long time,
breeders have been trying to develop blue roses, which have long been synonym for the impossible.In an effort to achieve this
breeders have been crossing rose varieties grown all around the world. As a result, there are so-called 'blue' roses already on the
market. However, blue roses, derived from the presence of blue pigment, have not yet come into being. It has been revealed that
this is a result of the fact that in rose petals genes encoding the enzyme that is necessary to create the blue pigment, "Delphinidin",
are not functional (the enzyme is known as flavonoid 3'5'-hydroxylase).

SUNTORY has focused on this finding and, in 1990, in cooperation with an Australian bio-venture company "Calgene Pacific (now:
Florigene Pty. Ltd.) started the joint development of biotechnology-driven "blue roses". Since then we have been pursuing our
research attempting to develop "blue roses" by retrieving the genes necessary to create blue pigments from other plants such as
petunia and implanting these into roses. The world's first "blue carnations" were born in this development process in 1995 and, in
Japan, they were named "Moondust" where they have been marketed since 1997

For the first time in the world, SUNTORY has succeeded in creating blue pigment in roses by implanting the gene that leads to the
synthesis of blue pigment from pansy. Unlike the roses created by using conventional breeding technologies, the roses developed
by us have almost 100%* Delphinidin in their petals, which has allowed these new and very different blue roses to become a reality.
Although traditional roses have only red pigments, by using the blue roses we have developed as a starting point, it is expected that
roses with the ability to create a blue pigment will soon lead more variety in rose flower colour.

The SUNTORY GROUP will continue our research and development to make blue roses "bluer". The roses have been evaluated
and approved based on the "Act concerning Maintenance of Diversity of Organisms regulated by Use of Genetically-Modified
Organisms" (http://www.mext.go.jp/a_menu/shinkou/seimei/main.htm) and we will consider merchandising after production,
distribution, and sales structures have been properly established. The SUNTORY GROUP was established in 1899 and since then
has been aggressively developing new businesses maintaining its "spirit of challenge". In this vein SUNTORY opened the way for
the successful marketing of well-known marks of "whisky", "draft beer", and not being confined to producing alcoholic beverages,
has also expanded into the soft drink business, the flower business, the health food business, cultural and sports activities. In
addition business sphere has been expanded to Europe, Asia and North America. We will continue our global business and efforts
to create innovative products showing our "spirit of challenge".
Florigene Pty. Ltd. was established as an Australian bio-venture company in 1986. It develops new varieties of plants by using
biotechnology. It is a world's leading company in the research of flower colour. SUNTORY LIMITED took over the company's shares
in December, 2003..